519 related articles for article (PubMed ID: 1532436)
1. [Coronary heart disease and lipoprotein (a): relationship with other lipid cardiovascular risk factors].
Nogués X; Sentí M; Pedro-Botet J; Molina L; Serrat R; Pons S; Rubiés-Prat J
Med Clin (Barc); 1992 Feb; 98(5):171-4. PubMed ID: 1532436
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.
Sandholzer C; Boerwinkle E; Saha N; Tong MC; Utermann G
J Clin Invest; 1992 Mar; 89(3):1040-6. PubMed ID: 1541665
[TBL] [Abstract][Full Text] [Related]
3. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
[TBL] [Abstract][Full Text] [Related]
4. Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus.
Murase T; Okubo M; Amemiya-Kudo M; Ebara T; Mori Y
Metabolism; 2008 Jun; 57(6):791-5. PubMed ID: 18502261
[TBL] [Abstract][Full Text] [Related]
5. [Elevated levels of lipoprotein(a) are present in subjects with early ischemic cardiopathy and with a familial history of ischemic cardiopathy].
Saitta A; Castaldo M; Sardo A; Cinquegrani M; Bonaiuto M; Zema M; Gravina M; Mangano C
Minerva Med; 1999; 90(5-6):151-8. PubMed ID: 10780189
[TBL] [Abstract][Full Text] [Related]
6. The effect of change of renal replacement therapy on serum lipoprotein (a) concentration.
Misra M; Webb AT; Reaveley DA; Doherty E; O'Donnell M; Seed M; Brown EA
Adv Perit Dial; 1997; 13():168-73. PubMed ID: 9360675
[TBL] [Abstract][Full Text] [Related]
7. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity.
Pietrzak A; Kadzielewski J; Janowski K; Roliński J; Krasowska D; Chodorowska G; Paszkowski T; Kapeć E; Jastrzebska I; Tabarkiewicz J; Lotti T
Int J Dermatol; 2009 Apr; 48(4):379-87. PubMed ID: 19335423
[TBL] [Abstract][Full Text] [Related]
9. [Plasma levels of lipids, lipoproteins and apolipoproteins affected by endogenous testosterone].
Zhao S; Li X; Wang Z
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(3):299-301. PubMed ID: 10681765
[TBL] [Abstract][Full Text] [Related]
10. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
[TBL] [Abstract][Full Text] [Related]
11. [Changes in high density lipoproteins in peripheral vascular disease].
Pedro-Botet J; Sentí M; Nogués X; Rubiés-Prat J; Vidal-Barraquer F
Med Clin (Barc); 1991 Apr; 96(13):493-5. PubMed ID: 2051792
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E genotypes and metabolic risk factors for coronary heart disease in middle-aged women.
Cubrilo-Turek M; Stavljenić-Rukavina A; Sertić J; Zrinski R; Turek S; Grgac G; Ljubojević N
Coll Antropol; 1998 Jun; 22(1):149-55. PubMed ID: 10097431
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
Cubrilo-Turek M; Sertić J; Duraković Z
Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
[TBL] [Abstract][Full Text] [Related]
15. [Cardiovascular disease-related serum lipid parameters in a Hungarian subpopulation].
Szépvölgyi J; Kravják BE; Bíró L; Nagy K; Bíró G; Antal M
Orv Hetil; 1997 Aug; 138(32):2005-8. PubMed ID: 9297170
[TBL] [Abstract][Full Text] [Related]
16. Association between incidence of lipoprotein(a) positivity and coronary heart disease.
Vashisht S; Wasir H; Srivastava LM
Indian Heart J; 1992; 44(4):223-6. PubMed ID: 1289218
[TBL] [Abstract][Full Text] [Related]
17. High density lipoprotein cholesterol low serum level as the only risk factor in male patients with coronary heart disease.
Alessandri C; Basili S; Peverini F; Barsi R; Paradiso M; Coppotelli L; Violi F; Cordova C
Clin Ter; 1992 Aug; 141(8):109-14. PubMed ID: 1395453
[TBL] [Abstract][Full Text] [Related]
18. Serum lipoprotein Lp(a) in obesity.
Donatelli M; Verga S; Vaccaro M; Russo V; Bucalo ML; Scarpinato A
Diabetes Res; 1992; 20(4):127-31. PubMed ID: 1345006
[TBL] [Abstract][Full Text] [Related]
19. Transfer of cholesterol and other lipids from a lipid nanoemulsion to high-density lipoprotein in heart transplant patients.
Puk CG; Bocchi EA; Lo Prete AC; Ferreira SM; Stolf NA; Maranhão RC
J Heart Lung Transplant; 2009 Oct; 28(10):1075-80. PubMed ID: 19782290
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein(a) particle concentration and lipoprotein(a) cholesterol assays yield discordant classification of patients into four physiologically discrete groups.
Konerman M; Kulkarni K; Toth PP; Jones SR
J Clin Lipidol; 2012; 6(4):368-73. PubMed ID: 22836074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
